Logos Capital's book
29 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | — | |
| Element Biosciences | Other Healthcare Technology Systems | $1.0B | — | — | |
| Mirador Therapeutics | — | $1.0B | — | — | |
| 35Pharma | — | $950.0M | — | — | |
| Odyssey Therapeutics | Biotechnology | $638.2M | — | — | |
| Diagonal Therapeutics | Drug Discovery | $458.5M | — | — | |
| Attovia Therapeutics | — | $370.0M | — | — | |
| Interius BioTherapeutics | — | $350.0M | — | — | |
| Aviceda Therapeutics | — | $346.5M | — | — | |
| Beacon Biosignals | — | $334.0M | — | — | |
| + 19 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 29 recorded positions
- ·Watchlist + alerts for Logos Capital's activity
Create free account
No card required